Advertisement
"As a long-standing leader in the fluorescent protein field, Clontech isproud to have been the first company to commercialize the GFP technology thatwas developed by Dr. Chalfie and Dr. Douglas Prasher, enabling GFP to be usedas a tool for cell biology research. Currently, we offer many fluorescentproteins that build upon the work of these three exceptional scientists,including the Fruit Fluorescent Proteins developed by Dr. Tsien," said CarolLou, General Manager of Clontech Laboratories, Inc.
Advertisement
GFP was initially discovered and characterized by Dr. Shimomura, whoisolated it from the jellyfish Aequorea victoria and discovered that it glowedbright green under ultraviolet light. Dr. Chalfie applied GFP to biologicalresearch, using it as a visual genetic tag to study biological phenomena inthe bacterium Escherichia coli and the model organism Caenorhabditis elegans.Dr. Roger Y. Tsien, a Howard Hughes Medical Institute Investigator of theUniversity of California, San Diego, furthered our general understanding ofhow GFP fluoresces and has engineered many fluorescent proteins, spanning awide spectrum of colors not found in nature. The use of these differentcolored variants has enabled scientists to follow several different biologicalprocesses at the same time.
About Clontech Laboratories, Inc.
Clontech Laboratories, Inc. develops, produces, and markets leading-edgebiological products to the life science market worldwide. Clontech hasapproximately 2,000 products that enable life science researchers to studygenes, their products, and their cellular function through the use ofinnovative and powerful tools for gene cloning, labeling, and expression; aswell as for elucidating protein:protein interactions; isolating and purifyingDNA and proteins; and conducting a wide variety of PCR experiments. Clontechis a wholly-owned subsidiary of Takara Bio Inc. For more information visithttp://www.clontech.com
About Takara Bio Inc.
Takara Bio Inc. is an innovative biotechnology company based in Shiga,Japan. As a world leader in biotechnology research and development, Takara Biowas the first company to market PCR technology in Japan and is also thedeveloper of the RetroNectin(R) reagent, which is a world-standard in genetherapy protocols. In addition to providing research reagents and equipment tothe life science research market, Takara Bio has active research and productdevelopment activities in the fields of gene and cell-based therapy, andagricultural biotechnology; and is committed to preventing disease andimproving the quality of life for all people through the use of biotechnology.Through strategic alliances with other industry leaders, the Company aims toextend its reach around the world. More information is available athttp://www.takara-bio.com
SOURCE Clontech Laboratories, Inc.
